| Application no. and date | 19186629.2 (espacenet) (Federated) (European Patent Register), 20170220 | | Patent/reg. no. and date | DK/EP 3604527, 20210512 | | Publication date | 20200205 | | Priority no. and date | US 201662344858 P, 20160602, US 201662358415 P, 20160705 | | EP pub. no. and date |
EP 3604527 20200205 | | Effective date | | | Applicant/owner | Sigma-Aldrich Co., LLC, 3050 Spruce Street
St. Louis, MO 63103, US | | Applicant ref. no. | V2105-044-DK | | Inventor | Chen, Fuqiang, 3050 Spruce Street
St Louis, MO 63103, US | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | C12N 15/10 (2006.01) , C12N 9/22 (2006.01) | | Title | ANVENDELSE AF PROGRAMMERBARE DNA-BINDINGSPROTEINER TIL AT FORBEDRE MÅLRETTET GENOMMODIFIKATION | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
